VTRLY (Vitrolife AB) Cash Flow from Others : $28.9 Mil (TTM As of Dec. 2024)

View and export this data going back to 2016. Start your Free Trial

What is Vitrolife AB Cash Flow from Others?

Vitrolife AB's cash flow from others for the three months ended in Dec. 2024 was $5.2 Mil. Its cash flow from others for the trailing twelve months (TTM) ended in Dec. 2024 was $28.9 Mil.

Vitrolife AB Cash Flow from Others Historical Data

The historical data trend for Vitrolife AB's Cash Flow from Others can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vitrolife AB Cash Flow from Others Chart

Vitrolife AB Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Cash Flow from Others

Get a 7-Day Free Trial

-12.57

-19.80

-12.72

404.19

27.40

Vitrolife AB Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Cash Flow from Others	Get a 7-Day Free Trial															419.30	9.03	6.29	8.41	5.19

Vitrolife AB Cash Flow from Others Calculation

Cash Flow from Others for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $28.9 Mil.

Vitrolife AB Cash Flow from Others Related Terms

Thank you for viewing the detailed overview of Vitrolife AB's Cash Flow from Others provided by GuruFocus.com. Please click on the following links to see related term pages.

Vitrolife AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Vitrolife AB (OTCPK:VTRLY) » Definitions » Cash Flow from Others

Comparable Companies

Traded in Other Exchanges

VITR:Sweden VITRs:UK 0YAY:UK VTFN:Germany

Address

Box 9080, Gothenburg, SWE, 400 92

Website

https://www.vitrolife.com

Vitrolife AB provides medical devices and genetic testing services intended for the reproductive-health market in the field of reproductive health. The company develops, manufactures, and distributes medical devices and provides genetic testing services for IVF clinics and their patients. Its mission is to support IVF clinics (in vitro fertilization) in enhancing their practice as well as the outcome of a patient's fertility treatment, thereby enabling patients to receive support to navigate the complexities of reproductive health through successful outcomes and patient satisfaction. The group has three geographical segments EMEA, Americas and APAC, out of which it derives maximum revenue from EMEA.